These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


192 related items for PubMed ID: 2579616

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cortical atrophy in schizophrenia and mania: a comparative CT study.
    Nasrallah HA, McCalley-Whitters M, Jacoby CG.
    J Clin Psychiatry; 1982 Nov; 43(11):439-41. PubMed ID: 7174617
    [Abstract] [Full Text] [Related]

  • 3. Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acid.
    Doran AR, Boronow J, Weinberger DR, Wolkowitz OM, Breier A, Pickar D.
    Neuropsychopharmacology; 1987 Dec; 1(1):25-32. PubMed ID: 3509912
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia.
    Houston JP, Maas JW, Bowden CL, Contreras SA, McIntyre KL, Javors MA.
    Psychiatry Res; 1986 Nov; 19(3):207-14. PubMed ID: 3797547
    [Abstract] [Full Text] [Related]

  • 6. Schizophrenic symptoms and deterioration. Relation to computed tomographic findings.
    Pandurangi AK, Bilder RM, Rieder RO, Mukherjee S, Hamer RM.
    J Nerv Ment Dis; 1988 Apr; 176(4):200-6. PubMed ID: 3351498
    [Abstract] [Full Text] [Related]

  • 7. Third ventricular enlargement on CT scans in schizophrenia: association with cerebellar atrophy.
    Nasrallah HA, Jacoby CG, Chapman S, McCalley-Whitters M.
    Biol Psychiatry; 1985 Apr; 20(4):443-50. PubMed ID: 3978176
    [Abstract] [Full Text] [Related]

  • 8. Monoamine metabolite levels in cerebrospinal fluid and brain atrophy in lobotomized schizophrenic patients.
    Rimón R, Roos BE, Kampman R, Hyyppä S, Ranta P, Myllylä V.
    Ann Clin Res; 1979 Feb; 11(1):25-9. PubMed ID: 453776
    [Abstract] [Full Text] [Related]

  • 9. Computerized tomography of the brain in schizophrenic patients. A controlled study.
    Tanaka Y, Hazama H, Kawahara R, Kobayashi K.
    Acta Psychiatr Scand; 1981 Mar; 63(3):191-7. PubMed ID: 6972151
    [Abstract] [Full Text] [Related]

  • 10. CSF chromogranin A-like immunoreactivity in schizophrenia. Assessment of clinical and biochemical relationships.
    van Kammen DP, Peters J, Yao J, Neylan T, Beuger M, Pontius E, O'Connor DT.
    Schizophr Res; 1991 Dec; 6(1):31-9. PubMed ID: 1723893
    [Abstract] [Full Text] [Related]

  • 11. Correlates of lateral ventricular size in chronic schizophrenia, II: biological measures.
    Losonczy MF, Song IS, Mohs RC, Mathé AA, Davidson M, Davis BM, Davis KL.
    Am J Psychiatry; 1986 Sep; 143(9):1113-8. PubMed ID: 2428259
    [Abstract] [Full Text] [Related]

  • 12. Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect.
    Shelton RC, Karson CN, Doran AR, Pickar D, Bigelow LB, Weinberger DR.
    Am J Psychiatry; 1988 Feb; 145(2):154-63. PubMed ID: 3277448
    [Abstract] [Full Text] [Related]

  • 13. Suicide and aggression in schizophrenia. Neurobiologic correlates.
    Pickar D, Roy A, Breier A, Doran A, Wolkowitz O, Colison J, Agren H.
    Ann N Y Acad Sci; 1986 Feb; 487():189-96. PubMed ID: 2436533
    [Abstract] [Full Text] [Related]

  • 14. Cortical and central atrophy in chronic schizophrenia. A controlled study.
    Okasha A, Madkour O.
    Acta Psychiatr Scand; 1982 Jan; 65(1):29-34. PubMed ID: 7187173
    [Abstract] [Full Text] [Related]

  • 15. Computed tomography scans and negative symptoms in schizophrenia: chronic schizophrenics with negative symptoms and nonenlarged lateral ventricles.
    Serban G, George A, Siegel S, DeLeon M, Gaffney M.
    Acta Psychiatr Scand; 1990 May; 81(5):441-7. PubMed ID: 2356766
    [Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.
    Pickar D, Breier A, Hsiao JK, Doran AR, Wolkowitz OM, Pato CN, Konicki PE, Potter WZ.
    Arch Gen Psychiatry; 1990 Jul; 47(7):641-8. PubMed ID: 1694425
    [Abstract] [Full Text] [Related]

  • 17. Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patients.
    Linnoila M, Ninan PT, Scheinin M, Waters RN, Chang WH, Bartko J, van Kammen DP.
    Arch Gen Psychiatry; 1983 Dec; 40(12):1290-4. PubMed ID: 6197036
    [Abstract] [Full Text] [Related]

  • 18. CT scan and MRI findings in a child with schizophrenia.
    Woody RC, Bolyard K, Eisenhauer G, Altschuler L.
    J Child Neurol; 1987 Apr; 2(2):105-10. PubMed ID: 3598138
    [Abstract] [Full Text] [Related]

  • 19. The ventricular system in chronic schizophrenic patients. A controlled computed tomography study.
    Pandurangi AK, Dewan MJ, Lee SH, Ramachandran T, Levy BF, Boucher M, Yozawitz A, Major L.
    Br J Psychiatry; 1984 Feb; 144():172-6. PubMed ID: 6608390
    [Abstract] [Full Text] [Related]

  • 20. Lateral ventricle-brain ratio and balance between CSF HVA and 5-HIAA in schizophrenia.
    Lewine RR, Risch SC, Risby E, Stipetic M, Jewart RD, Eccard M, Caudle J, Pollard W.
    Am J Psychiatry; 1991 Sep; 148(9):1189-94. PubMed ID: 1715677
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.